| [1] Li YD，Xu J，Zou HJ，et al. 1-MT enhances potency of tumor cell lysate-pulsed dendritic cells against pancreatic adenocar-cinoma by downregulating the percentage of Tregs[J]. Hua zhong Univ Sci Technol，2010，30 (3)：206-211. [2] Rikke BS，Tania K，Rikke SA，et al. Spontaneous cytotoxic T-cell reactivity against indoleamine 2，3-Dioxygenase-2[J] . Cancer Res，2011，71 (6)：2038-2044. [3] Sakurai K，Fujisaki S，Nagashima S，et al. Indoleamine 2，3- dioxygenase activity during chemotherapy or trastuzumab therapy in patients with breast cancer[J]. Gan To Kagaku Ryoho 2012，39 (12)：1791-1793. [4] Monica CS，Pilar M，Reyes DS，et al. Changes in the levels of thioredoxin andindoleamine-2，3-dioxygenase activity in plasma of patients with colorectal cancer treated with chemo-therapy[J]. Biochem Cell Biol，2012，90 (15)：173–178. [5] Mildred LM，June ADA，Zachary MG，et al. The cystine/glutamate antiporter regulates indoleamine 2，3-dioxygenase protein levels and enzymatic activity in human dendritic cells[J]. Immunol， 2012，1 (2)：113-123. [6] Dagmar VB，Marina S，Hele W，et al. Identification of IDO-positive and IDO-negative human dendritic cells after activation by various proinflammatory stimuli[J]. J Immunol，2011，186 (22)：6701–6709. [7] Shatz M，Menendez D，Resnick MA，et al. The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells[J]. Cancer Res，2012，72 (16)：3948-3957. [8] Hou DY，Muller AJ，Sharma MD，et al. Inhibition of indoleamine 2，3-dioxygenase in dendritic cell by steroisomers of 1-methyl-tryptophan correlates with antitumor responses[J]. Cancer Res， 2007，67 (9)：792-801. [9] Obeid M，Tesniere A ，Ghiringhelli F，et al. Calreticulin exposure dictates the immunogenicity of cancer cell death[J]. Nat Med， 2007，13 (1)：54-61． |
